| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec3d7a9a543c4214ef75cdabb2d0e04b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
| filingDate |
2014-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb9ad8135c2a74b40e18a4e9f0392f9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ffa89bdf4172fe6888fe654ba1c16e3 |
| publicationDate |
2015-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015061686-A2 |
| titleOfInvention |
Retinoid x receptor-gamma agonists and retinoid x receptor-alpha antagonists for treatment of cancer |
| abstract |
The invention is directed to the use of Retinoid X Receptor-gamma (RXR-gamma) agonists and Retinoid X Receptor-alpha (RXR-alpha) antagonists in treatment of cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9902715-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9902735-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9868724-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017190420-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111057120-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10005731-B2 |
| priorityDate |
2013-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |